PARP10 inhibitors: PARP10 is presented as an attractive therapeutic target in cancer and neurodegenerative diseases [36] since it regulates cell proliferation through multiple pathways of the β-catenin pathway in addition to playing a regulatory role in replication and in the mitochondrial response to oxidative stress [36,67,98]. Here, PARP10 is linked to neurodegenerative disease.